Garry Nolan - 09 Dec 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
09 Dec 2021
Transactions value $
-$316,763
Form type
4
Filing time
13 Dec 2021, 17:06:05 UTC
Previous filing
25 May 2021
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale -$316,762 -25,000 -3.68% $12.67 655,084 09 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Column 4 reflects a weighted average price. Shares sold in multiple transactions at prices ranging from $12.59-$12.74. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.